The Pathophysiology of Bullous Pemphigoid

Overview

Journal Clin Rev Allergy Immunol

Specialty Allergy & Immunology

Date 2007 Dec 21

PMID 18094948

Citations 64

Authors

Michael Kasperkiewicz

Detlef Zillikens

Affiliations

Soon will be listed here.

Abstract

Bullous pemphigoid (BP) is a blistering skin disease characterized by an autoimmune response to 2 hemidesmosomal proteins within the dermal-epidermal junction, designated BP180 and BP230. While BP230 localizes intracellularly and associates with the hemidesmosomal plaque, BP180 is a transmembrane glycoprotein with an extracellular domain. Most BP patients have autoantibodies binding to an immunodominant region of BP180, the noncollagenous 16A domain (NC16A), which is located extracellularly close to the transmembrane domain of the protein. Autoreactive T and B cell responses to BP180 have been found in patients with BP. Passive transfer of antibodies to the murine BP180 ectodomain triggers a blistering skin disease in mice that closely mimics human BP. Lesion formation in this animal model depends upon complement activation, mast cell degranulation and accumulation of neutrophils and eosinophils. Patients' autoantibodies to BP180 induce dermal-epidermal separation in cryosections of human skin when co-incubated with leukocytes. The loss of cell-matrix adhesion is mediated by proteinases released by granulocytes. The increased knowledge of the pathophysiology of BP should facilitate the development of novel therapeutic strategies for this disease.

Citing Articles

The emerging role of neutrophil extracellular traps in autoimmune and autoinflammatory diseases.

Zeng L, Xiang W, Xiao W, Wu Y, Sun L MedComm (2020). 2025; 6(3):e70101.

PMID: 40060194 PMC: 11885892. DOI: 10.1002/mco2.70101.

Dyshidrosiform Bullous Pemphigoid: A Palmar Variant of a Common Disease.

Lum A, Brady M Cureus. 2025; 16(12):e75639.

PMID: 39803042 PMC: 11725341. DOI: 10.7759/cureus.75639.

Educational Case: Bullous pemphigoid.

Saal R, Roberts A, Conran R Acad Pathol. 2025; 12(1):100155.

PMID: 39758589 PMC: 11696843. DOI: 10.1016/j.acpath.2024.100155.

Pathophysiology of Bullous Pemphigoid: Role of Type 2 Inflammation and Emerging Treatment Strategies (Narrative Review).

Werth V, Murrell D, Joly P, Heck R, Orengo J, Ardeleanu M Adv Ther. 2024; 41(12):4418-4432.

PMID: 39425892 PMC: 11550233. DOI: 10.1007/s12325-024-02992-w.

Lymphocytic infiltration as a marker of disease severity in patients with bullous pemphigoid-A case series.

Mathur M, Thakur N, Das G, Paudel S, Jaiswal S Clin Case Rep. 2024; 12(6):e9084.

PMID: 38883217 PMC: 11176721. DOI: 10.1002/ccr3.9084.

References

Yamamoto K, Inoue N, Masuda R, Fujimori A, Saito T, Imajoh-Ohmi S . Cloning of hamster type XVII collagen cDNA, and pathogenesis of anti-type XVII collagen antibody and complement in hamster bullous pemphigoid. J Invest Dermatol. 2002; 118(3):485-92. DOI: 10.1046/j.0022-202x.2001.01683.x. View

Springer T . Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 1994; 76(2):301-14. DOI: 10.1016/0092-8674(94)90337-9. View

Kobayashi M, Amagai M, Hashimoto T, Shirakata Y, Hashimoto K, Nishikawa T . BP180 ELISA using bacterial recombinant NC16a protein as a diagnostic and monitoring tool for bullous pemphigoid. J Dermatol Sci. 2002; 30(3):224-32. DOI: 10.1016/s0923-1811(02)00109-3. View

Ide A, Hashimoto T, Amagai M, Tanaka M, Nishikawa T . Detection of autoantibodies against bullous pemphigoid and pemphigus antigens by an enzyme-linked immunosorbent assay using the bacterial recombinant proteins. Exp Dermatol. 1995; 4(2):112-6. DOI: 10.1111/j.1600-0625.1995.tb00232.x. View

Jordon R, Heine K, Tappeiner G, Bushkell L, Provost T . The immunopathology of herpes gestationis. Immunofluorescence studies and characterization of "HG factor". J Clin Invest. 1976; 57(6):1426-31. PMC: 436801. DOI: 10.1172/JCI108412. View

Welgus H, Bauer E, Stricklin G . Elevated levels of human collagenase inhibitor in blister fluids of diverse etiology. J Invest Dermatol. 1986; 87(5):592-6. DOI: 10.1111/1523-1747.ep12455837. View

Galli S . New concepts about the mast cell. N Engl J Med. 1993; 328(4):257-65. DOI: 10.1056/NEJM199301283280408. View

Sitaru C, Schmidt E, Petermann S, Munteanu L, Brocker E, Zillikens D . Autoantibodies to bullous pemphigoid antigen 180 induce dermal-epidermal separation in cryosections of human skin. J Invest Dermatol. 2002; 118(4):664-71. DOI: 10.1046/j.1523-1747.2002.01720.x. View

He S, Peng Q, Walls A . Potent induction of a neutrophil and eosinophil-rich infiltrate in vivo by human mast cell tryptase: selective enhancement of eosinophil recruitment by histamine. J Immunol. 1998; 159(12):6216-25. View

10.

Jordon R, BEUTNER E, Witebsky E, Blumental G, Hale W, Lever W . Basement zone antibodies in bullous pemphigoid. JAMA. 1967; 200(9):751-6. View

11.

Galli S, Gordon J, Wershil B . Cytokine production by mast cells and basophils. Curr Opin Immunol. 1991; 3(6):865-72. DOI: 10.1016/s0952-7915(05)80005-6. View

12.

Van den Bergh F, Giudice G . BP180 (type XVII collagen) and its role in cutaneous biology and disease. Adv Dermatol. 2003; 19:37-71. View

13.

Bernard P, Aucouturier P, Denis F, Bonnetblanc J . Immunoblot analysis of IgG subclasses of circulating antibodies in bullous pemphigoid. Clin Immunol Immunopathol. 1990; 54(3):484-94. DOI: 10.1016/0090-1229(90)90060-4. View

14.

Leyendeckers H, Tasanen K, Bruckner-Tuderman L, Zillikens D, Sitaru C, Schmitz J . Memory B cells specific for the NC16A domain of the 180 kDa bullous pemphigoid autoantigen can be detected in peripheral blood of bullous pemphigoid patients and induced in vitro to synthesize autoantibodies. J Invest Dermatol. 2003; 120(3):372-8. DOI: 10.1046/j.1523-1747.2003.12071.x. View

15.

Borrego L, Maynard B, Peterson E, George T, Iglesias L, Peters M . Deposition of eosinophil granule proteins precedes blister formation in bullous pemphigoid. Comparison with neutrophil and mast cell granule proteins. Am J Pathol. 1996; 148(3):897-909. PMC: 1861728. View

16.

Labib R, Anhalt G, Patel H, Mutasim D, Diaz L . Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting. J Immunol. 1986; 136(4):1231-5. View

17.

Suzuki M, Harada S, Yaoita H . Purification of bullous pemphigoid IgG subclasses and their capability for complement fixation. Acta Derm Venereol. 1992; 72(4):245-9. DOI: 102340/0001555572245249. View

18.

dAuria L, Pietravalle M, Mastroianni A, Ferraro C, Mussi A, Bonifati C . IL-5 levels in the serum and blister fluid of patients with bullous pemphigoid: correlations with eosinophil cationic protein, RANTES, IgE and disease severity. Arch Dermatol Res. 1998; 290(1-2):25-7. DOI: 10.1007/s004030050272. View

19.

Dimson O, Giudice G, Fu C, Van den Bergh F, Warren S, Janson M . Identification of a potential effector function for IgE autoantibodies in the organ-specific autoimmune disease bullous pemphigoid. J Invest Dermatol. 2003; 120(5):784-8. DOI: 10.1046/j.1523-1747.2003.12146.x. View

20.

Green K, Virata M, Elgart G, Stanley J, Parry D . Comparative structural analysis of desmoplakin, bullous pemphigoid antigen and plectin: members of a new gene family involved in organization of intermediate filaments. Int J Biol Macromol. 1992; 14(3):145-53. DOI: 10.1016/s0141-8130(05)80004-2. View